Edwards Lifesciences CFO to Retire, Board OKs $750 Million Share Buyback

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Medical devices maker Edwards Lifesciences Corp. (EW: Quote) said Tuesday that Chief Financial Officer Thomas Abate plans to retire later this year. In addition, the company said its board of directors has authorized a new $750 million share repurchase program, while CEO Michael Mussallem will purchase $5 million in Edwards stock.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC